Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2

Cited by (197)

Items 101–197 of 197

1. SARS-CoV-2–neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma
   Jakob J Malin, Veronica Di Cristanziano, Carola Horn, Elisabeth Pracht, Jorge Garcia Borrega, Eva Heger, Elena Knops, Rolf Kaiser, Boris Böll, Clara Lehmann et al. · 2021 · Blood Advances
2. Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany
   Alex Dulovic, Barbora Kessel, Manuela Harries, Matthias Becker, Julia Ortmann, Johanna Griesbaum, Jennifer Juengling, Daniel Junker, Pilar Hernández, Daniela Gornyk et al. · 2022 · Frontiers in Immunology
3. Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy
   Michal Podrazil, Pavla Táborská, Dmitry Stakheev, Michal Rataj, Jan Lašťovička, Alena Vlachova, Petr Pohunek, Jiřina Bartůňková, Daniel Smrž · 2022 · Frontiers in Immunology
4. Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice
   Etsuro Nanishi, Francesco Borriello, Hyuk‐Soo Seo, Timothy R. O’Meara, Marisa E. McGrath, Yoshine Saito, Jing Chen, Joann Diray‐Arce, Kijun Song, Andrew Z. Xu et al. · 2023 · npj Vaccines
5. The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders
   Dalin Li, Alexander M. Xu, Emebet Mengesha, Rebecca Elyanow, Rachel Gittelman, Heidi Chapman, John C. Prostko, Edwin C. Frias, James L. Stewart, Valeriya Pozdnyakova et al. · 2021 · medRxiv
6. COVID-19 vaccination exacerbates ex vivo IL-6 release from isolated PBMCs
   Dominik Langgartner, Raphael Winkler, Jonas Brunner-Weisser, Nicolas Rohleder, Marc Nicolas Jarczok, Harald Gündel, Katja Weimer, Stefan Oskar Reber · 2023 · Scientific Reports
7. Powder-attached microneedles for the stable and effective transdermal delivery of clinically validated mRNA-LNP vaccine
   Ji Seok Kim, Na-Eun Kim, Jung-ah Choi, In‐Jeong Choi, Jeong-Eun Choi, Aram Kang, Danbi Kwon, Mihwa Lim, Jooyoung Kim, Seung‐Ki Baek et al. · 2025 · European Journal of Pharmaceutics and Biopharmaceutics
8. Essential role for Batf3-dependent dendritic cells in regulating CD8 T-cell response during SARS-CoV-2 infection
   Liat Bar‐On, Hani Dekel Jaoui, Moshe Aftalion, Theodor Chitlaru, Noam Erez A · 2023 · PLoS ONE
9. The BNT162b2 mRNA vaccine demonstrates reduced age-associated TH1 support in vitro and in vivo
   Byron Brook, Benoit Fatou, Soumik Barman, Soumik Barman, Cali Sweitzer, Anna-Nicole Bosco, Amy Sherman, Lindsey Baden, Elena Morrocchi, Guzman Sánchez‐Schmitz et al. · 2024 · iScience
10. Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection
    Momtchilo Russo, Maria Cássia Mendes-Corrêa, Bruna Bezerra Lins, Victor Kersten, Paulo Castanho A. Pernambuco Filho, Toni Ricardo Martins, Tânia Regina Tozetto‐Mendoza, Lucy Santos Vilas Boas, Brisa Moreira Gomes, Lívia Mendonça Munhoz Dati et al. · 2023 · Vaccines
11. In vitro high-content tissue models to address precision medicine challenges
    Samson Afewerki, T. Stocco, Andre Diniz Rosa da Silva, André Sales Aguiar Furtado, Gustavo Fernandes de Sousa, G. Ruiz-Esparza, T. Webster, F. R. Marciano, M. Strømme, Y. Zhang et al. · 2022 · Molecular Aspects of Medicine
12. Steroid treatment suppresses the CD4+ T-cell response to the third dose of mRNA COVID-19 vaccine in systemic autoimmune rheumatic disease patients
    Avishai Maliah, Roma Parikh, Oshrat E Tayer-Shifman, Oded Kimhi, Raz Gepstein, Tami Halperin, Yair M. Levy, Carmit Levy, Yael Pri-Paz Basson, Shaye Kivity · 2022 · Scientific Reports
13. SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
    Eun Kim, Muhammad S. Khan, Alessandro Ferrari, Shaohua Huang, Josè Camilla Sammartino, Elena Percivalle, Thomas W. Kenniston, Irene Cassaniti, Fausto Baldanti, Andrea A. Gambotto · 2023 · Microbiology Spectrum
14. Longitudinal kinetics of RBD+ antibodies in COVID-19 recovered patients over 14 months
    Tsuf Eyran, Anna Vaisman‐Mentesh, David Taussig, Yael Dror, Ligal Aizik, Aya Kigel, Shai Rosenstein, Yael Bahar, Dor Ini, Ran Tur‐Kaspa et al. · 2022 · PLoS Pathogens
15. A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
    Brandon Carter, Pinghan Huang, Ge Liu, Yuejin Liang, Paulo J.C. Lin, Bi‐Hung Peng, Lindsay G. A. McKay, Alexander Dimitrakakis, Jason C. Hsu, Vivian Tat et al. · 2023 · Frontiers in Immunology
16. Advancing Lung Immunology Research: An Official American Thoracic Society Workshop Report
    Rod A. Rahimi, Josalyn L. Cho, Claudia Jakubzick, Shabaana A. Khader, Bart N. Lambrecht, Clare M. Lloyd, Ari B. Molofsky, Sébastien Talbot, Catherine A. Bonham, Wonder P. Drake et al. · 2022 · American Journal of Respiratory Cell and Molecular Biology
17. Exploring the dynamics of SARS-CoV-2 and HIV Co-infection: Mutation risks, therapeutic efficacy, and future variant prevention
    Sumaiya Tasnim Maliha, Rabeya Fatemi, Marjana Akter, Qingcong Zheng, Yusha Araf, Tahani Tabassum, Mohammad Raguib Munif, Sukumar Saha, Mengzhou Xue, Huiqing Wang et al. · 2025 · Diagnostic Microbiology and Infectious Disease
18. Neutralizing antibody responses to three XBB protein vaccines in older adults
    Guojian Yang, Mei Lu, Rui-Rui Chen, Shuang-Qing Wang, Sheng Wan, Xuedong Song, Guo-Ping Cao, Lei Lv, Xue-Juan He, Bingdong Zhan et al. · 2025 · Signal Transduction and Targeted Therapy
19. A Dual‐Adjuvanted Parenteral‐Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS‐CoV‐2 in Mice
    Bhawana Pandey, Zhengying Wang, Angela C. Jimenez, Eshant Bhatia, Ritika Jain, Alexander Beach, Drishti Maniar, Justin Hosten, Laura O’Farrell, Casey E. Vantucci et al. · 2024 · Advanced Science
20. Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine
    Floriane Gallais, Pierre Gantner, Delphine Planas, Morgane Solis, Timothée Bruel, Florian Pierre, Eric Soulier, Paola Rossolillo, Slim Fourati, Jean Sibilia et al. · 2022 · Frontiers in Immunology
21. What has vaccination against COVID-19 in CKD patients taught us?
    Mattia Rossi, Giuseppina Pessolano, Giovanni Gambaro · 2023 · Journal of Nephrology
22. Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy
    Julia Davis‐Porada, Ceren Tozlu, Claudia Aiello, Sokratis A. Apostolidis, Amit Bar‐Or, Riley M. Bove, Diego A. Espinoza, Sugeidy Ferreira Brito, Dina A. Jacobs, Mihir Kakara et al. · 2025 · npj Vaccines
23. Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models
    Hong‐Yi Zheng, 中国科学院昆明动物研究所遗传资源与进化国家重点实验室, 生物安全大科学中心, 中国科学院昆明动物研究所-香港中文大学生物资源与疾病分子机理联合实验室, 云南 昆明 650223, 中国, Tian‐Zhang Song, Yong‐Tang Zheng, 中国科学院昆明动物研究所模式动物表型与遗传研究国家重大科技基础设施(灵长类设施), 国家非人灵长类实验动物资源库, 云南 昆明 650107, 中国 · 2024 · 动物学研究
24. A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants
    Tian-Jiao Hao, Yu-Lei Li, Peipei Liu, Xi Wang, Ke Xu, Wen-Wen Lei, Ying Li, Rong Zhang, Xiaoyan Li, Xin Zhao et al. · 2024 · PLoS Pathogens
25. T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome
    Cansu Cimen Bozkus, Matthew Brown, Leandra G. Velazquez, Marcus Thomas, Eric A. Wilson, Timothy J. O’Donnell, Anna Kaminska, Denis Ruchnewitz, Douglas Geertz, Yonina Bykov et al. · 2025 · iScience
26. Comparison of the Clinical and Laboratory Findings and Outcomes of Hospitalized COVID-19 Patients Who Were Either Fully Vaccinated with Coronavac or Not: An Analytical, Cross Sectional Study
    Serap Şimşek Yavuz, Gülşah Tunçer, Özlem Altuntaş Aydın, Mehtap Aydın, Filiz Pehlıvanoglu, Yeşim Tok, Sevim Meşe, Alper Gündüz, Ceyda Geyiktepe-Güçlü, İklima Özdoğan et al. · 2022 · Vaccines
27. Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccination
    Yapei Huang, Juliana E. Shin, Alexander M. Xu, Changfu Yao, Sandy Y. Joung, Min Wu, Ruan Zhang, Bongha Shin, Joslyn Foley, Simeon Mahov et al. · 2022 · iScience
28. Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies
    Ernest T. Aguinam, Angalee Nadesalingam, Andrew Chan, Peter Smith, Minna Paloniemi, Diego M. Cantoni, Jessica Gronlund, Helen Gronlund, George Carnell, Javier Castillo‐Olivares et al. · 2023 · Journal of Allergy and Clinical Immunology Global
29. Time course of antibody concentrations against the spike protein of SARS‐CoV‐2 among healthy hospital workers up to 200 days after their first COVID‐19 vaccination
    Thomas Mueller · 2021 · Journal of Clinical Laboratory Analysis
30. Evaluación de la respuesta de los anticuerpos IGG específicos contra SARS-CoV-2 en el personal de salud con el esquema completo de la vacuna Sputnik V (Gam-COVID-Vac)
    Ezequiel Córdova, María Inés Lespada, Diego M. Cecchini, Fabiola Nieto, Susana Palonsky, Mariana Badran, Silvina Virginia Bernasconi, Brenda Bacelar, Laura Morganti, F. Garibaldi et al. · 2022 · Vacunas
31. The mRNA vaccine BNT162b2 demonstrates impaired TH1 immunogenicity in human elders in vitro and aged mice in vivo
    Byron Brook, Benoit Fatou, Abhinav Kumar Checkervarty, Soumik Barman, Cali Sweitzer, Anna-Nicole Bosco, Amy C Sherman, Lindsey Robert Baden, Elena Morrocchi, Guzman Sánchez‐Schmitz et al. · 2022 · Research Square
32. A lipid nanoparticle-mRNA vaccine provides potent immunogenicity and protection against Mycobacterium tuberculosis
    Hannah Lukeman, Hareth A. Al-Wassiti, Stewart A. Fabb, Leonard Lim, Trixie Wang, Warwick J. Britton, Megan C. Steain, Colin William Pouton, James A. Triccas, Claudio Counoupas · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
33. Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection
    Zezhong Liu, Jie Zhou, Ruiyu Gao, Yanqun Wang, M Liu, Weijie Wang, Yuanzhou Wang, Peilan Wei, Kaicheng Zhou, Muzhuo Wang et al. · 2026 · Nature Nanotechnology
34. The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
    Manish K. Dhawan, Nanamika Thakur, Manish Kumar Sharma, Ali Ahmed Rabaan · 2025 · Biomedicine & Pharmacotherapy
35. SARS-CoV-2 Transmission Risk Model in an Urban Area of Mexico, Based on GIS Analysis and Viral Load
    Victor Wagner Barajas-Carrillo, Carlos Eduardo Covantes‐Rosales, Mercedes Zambrano-Soria, Lucia Amapola Castillo-Pacheco, Daniel Alberto Girón‐Pérez, Ulises Mercado‐Salgado, Ansonny Jhovanny Ojeda-Durán, Erica Yolanda Vázquez-Pulido, Manuel Iván Girón‐Pérez · 2022 · International Journal of Environmental Research and Public Health
36. Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home
    María del Mar Pozo‐Balado, Ángel Bulnes‐Ramos, Israel Olivas‐Martínez, Vanesa Garrido‐Rodríguez, Carmen Lozano, Ana Isabel Álvarez‐Ríos, Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara et al. · 2023 · Immunity & Ageing
37. Can B cell‐deficient patients rely on COVID ‐19 vaccine‐induced T‐cell immunity?
    Tanaya Shree · 2022 · British Journal of Haematology
38. Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron (B.1.1.529)
    Yu Gao, Curtis Cai, Alba Grifoni, Thomas R Müller, Julia Niessl, Anna Olofsson, Marion Humbert, Lotta Hansson, Anders Österborg, Peter Bergman et al. · 2022 · Research Square
39. Integrated Organ Immunity: Antigen-specific CD4-T cell-derived IFN-γ induced by BCG imprints prolonged lung innate resistance against respiratory viruses
    Audrey W. Q. Lee, Katharine A. Floyd, Shengyang Wu, Zhuoqing Fang, Tze-Kai Tan, Chunfeng Li, Harold Sai-yin Hui, David Scoville, Alistaire D. Ruggiero, Yan Liang et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
40. Coordinated early immune response in the lungs is required for effective control of SARS-CoV-2 replication
    Klara Lenart, Hendrik Feuerstein, Mariana Prado Marmorato, Laura Perez Vidakovics, Gerald M. McInerney, Mimi Guebre‐Xabier, Jessica F. Trost, Bengt Eriksson, Gale Smith, Nita Patel et al. · 2025 · Nature Communications
41. Rewired type I IFN signaling is linked to age-dependent differences in COVID-19
    Lev Petrov, Sophia Brumhard, Sebastian Wisniewski, Philipp Georg, David Hillus, Anna Luisa Hiller, Rosario Astaburuaga-García, Nils Blüthgen, Emanuel Wyler, Katrin Vogt et al. · 2025 · Cell Reports Medicine
42. Protection conferred by mucosal novel bivalent Klebsiella pneumoniae vaccine immunization associates with presence of lung CD4+ TRM
    BiXia Liu, YaRu Gu, Yangxue Ou, LuXuan Liu, Wenhao Wang, JinRui Zhou, Ying Wang, YeXiang Du, Jing Xie, Yuan Liu et al. · 2025 · Microbes and Infection
43. The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study
    So Yun Lim, Jun-Won Kim, Ji Yeun Kim, Sung‐Woon Kang, Choi‐Young Jang, Euijin Chang, Jeong‐Sun Yang, Kyung-Chang Kim, Hee‐Chang Jang, Da Sol Kim et al. · 2023 · The Journal of Infectious Diseases
44. 22q11.2 Deletion and Duplication Syndromes and COVID-19
    Terrence Blaine Crowley, Donna McDonald McGinn, Kathleen E. Sullivan, International q11.2 COVID group report, Caterina Cancrini, Andrew Richard Gennery, Dinakantha S Kumararatne, Donna McDonald McGinn, Sólveig Óskarsdóttir, Alex Richter et al. · 2022 · Journal of Clinical Immunology
45. Helminth exposure protects against murine SARS-CoV-2 infection through macrophage dependent T cell activation
    Kerry L. Hilligan, Oyebola O. Oyesola, Sivaranjani Namasivayam, Nina Howard, Chad S. Clancy, Sandra D. Oland, Nicole L. Garza, Bernard A. P. Lafont, Reed F. Johnson, Katrin D. Mayer-Barber et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
46. mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice
    Xiaoming Liang, Yuxia Yuan, Junbin Wang, Cong Tang, Yun Kai Yang, Yanan Zhou, Hao Yang, Qing Huang, Wenhai Yu, Haixuan Wang et al. · 2025 · npj Vaccines
47. Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice
    Liat Bar‐On, Moshe Aftalion, Efi Makdasi, David Gur, Ron Alcalay, Hila Cohen, Adi Beth-Din, Ronit Rosenfeld, Hagit Achdout, Erez Bar‐Haim et al. · 2022 · Vaccines
48. Assessment of formation and durability of adaptive immunity in COVID-19 convasescents
    Ivanova Ia, Anna V. Filippenko, Anastasia A. Trufanova, N. D. Omelchenko, О. С. Чемисова, Aleksej S. Vodopyanov, Елена Александровна Березняк, Elena P. Sokolova, А. К. Носков, Areg A. Totolyan · 2023 · Russian Journal of Infection and Immunity
49. SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters
    Ming-Shu Hsieh, Chia-Wei Hsu, Hung‐Chun Liao, Chang-Ling Lin, Chen-Yi Chiang, Mei‐Yu Chen, Shih‐Jen Liu, Ching‐Len Liao, Hsin–Wei Chen · 2024 · Journal of Virology
50. A review of the clinical characteristics and management of immunosuppressed patients living with HIV or solid organ transplants infected with SARS-CoV-2 omicron variants
    Yan Song, Lixin Lou, Kaiyu Zhang · 2024 · Frontiers in Public Health
51. Early Isolates of SARS-CoV-2 Result in Different Pathogenesis in the Transduced Mouse Model of COVID-19
    Sophie J. Smither, Sarah L. Kempster, Simon Lawrence Priestnall, Alejandro Suárez‐Bonnet, Helen L. Stapleton, Thomas R. Laws, Deborah Ferguson, Neil M. Almond, Mark S. Lever, Ethel Diane Williamson · 2022 · Viruses
52. SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
    Charlie Fricke, Florian Pfaff, Lorenz Ulrich, Nico Joël Halwe, Jacob Schön, Laura Timm, Weda Hoffmann, Susanne Rauch, Benjamin Petsch, Donata Hoffmann et al. · 2023 · European Journal of Immunology
53. Inactivated whole virion vaccine protects K18‐hACE2 Tg mice against the Omicron SARS‐CoV‐2 variant via cross‐reactive T cells and nonneutralizing antibody responses
    Andrey Kruglov, Marina A. Bondareva, Violetta S. Gogoleva, Iaroslav K. Semin, Irina V. Astrakhantseva, Ruslan V. Zvartsev, Aleksandr S. Lunin, Vasiliy D. Apolokhov, Elena Yu. Shustova, Viktor P. Volok et al. · 2023 · European Journal of Immunology
54. Impact of memory T cells on SARS-CoV-2 vaccine response in hematopoietic stem cell transplant
    Jennifer VanOudenhove, Yuxin Liu, Raman V. Nelakanti, Dongjoo Kim, Emma Busarello, Natalia Tijaro Ovalle, Zhihong Qi, Padmavathi Mamillapalli, Alexa J. Siddon, Zhiliang Bai et al. · 2025 · PLoS ONE
55. A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
    Brandon Carter, Pinghan Huang, Ge Liu, Yuejin Liang, Paulo J.C. Lin, Bi‐Hung Peng, Lindsay G. A. McKay, Alexander Dimitrakakis, Jason C. Hsu, Vivian Tat et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
56. A transferable SARS-CoV-2 IRES module enables dual translation initiation for enhanced antigen expression in COVID-19 mRNA vaccines
    Han Young Seo, Haewon Jung, Seyoung Lee, Hae-Gwang Jung, Hee Cho, Yu-Min Son, Yeonju Bak, Seo-Yeon Hwang, Jung-Hee Kim, In Ho Park et al. · 2026 · Molecular Therapy — Nucleic Acids
57. Protracted COVID ‐19 pneumonitis early post‐ABO incompatible kidney transplantation: Management considerations and the role of whole genome sequencing
    Sara T. Stoler, Sebastiaan J. van Hal, Steven James Chadban, Thomas Le, Paul John Torzillo, Rose‐Marie Scarlato, Kate Wyburn, Griffith Boord Perkins, Tina M. Marinelli · 2023 · Nephrology
58. Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in Children
    Megan A. Files, Lauren E. Gentles, Leanne Kehoe, Amanda Adler, Kirsten Lacombe, Jane A. Dickerson, Alexander L. Greninger, Alpana Waghmare, Tarayn A. Fairlie, Kimberly D. Pringle et al. · 2024 · The Journal of Infectious Diseases
59. Enhancing Immune Responses against SARS-CoV-2 Variants in Aged Mice with INDUK: A Chimeric DNA Vaccine Encoding the Spike S1-TM Subunits
    Lishan Cui, Junbiao Wang, Fiorenza Orlando, Robertina Giacconi, Marco Malavolta, Beatrice Bartozzi, Roberta Galeazzi, Giorgia Giorgini, Luca Pesce, Francesco Cardarelli et al. · 2024 · ACS Omega
60. An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant
    Ryuta Uraki, Maki Kiso, Mutsumi Ito, Seiya Yamayoshi, Peter Halfmann, Shilpi Jain, Mehul S. Suthar, Tiago J. S. Lopes, Nao Jounai, Kazuki Miyaji et al. · 2025 · EBioMedicine
61. Antigen-presenting cells and lung CD8⁺ resident memory T cells coordinate local immune protection and shape responses to respiratory virus infection
    Takumi Kawasaki, Moe Ikegawa, Taro Kawai · 2025 · International Immunology
62. The T cell receptor repertoire reflects the dynamics of the immune response to vaccination
    Kevin Mohammed, Austin Meadows, Saboor Hekmaty, Sandra Hatem, Viviana R. Simon, Anitha Devi Jayaprakash, Ravi Sachidanandam · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
63. Low-dose bivalent mRNA vaccine is highly effective against different SARS-CoV-2 variants in a transgenic mouse model
    Björn Corleis, Donata Hoffmann, Susanne Rauch, Charlie Fricke, Nicole Roth, Janina Gergen, Kristina Kovacikova, Kore Schlottau, Nico Joël Halwe, Lorenz Ulrich et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
64. Intranasal hemagglutinin protein boosters induce robust mucosal immunity and cross-protection against influenza A viral challenge
    Miyu Moriyama, Gisele Regina Rodrigues, Jiping Wang, Andrew Hudak, Huiping Dong, Robert Homer, Drew Weissman, Shuangge Ma, Akiko Iwasaki · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
65. Altered COVID-19 immunity in children with asthma by atopic status
    Sherry Tong, Jordan C. Scott, Enwono Eyoh, Derek Werthmann, Addison E. Stone, Amelie E. Murrell, Gilberto Sabino‐Santos, Ivy V. Trinh, Sruti Chandra, Debra Holton Elliott et al. · 2024 · Journal of Allergy and Clinical Immunology Global
66. Conserved CD8 T cell vaccines without B cell epitopes drive robust protection against SARS-CoV-2 that is enhanced by intranasal boost
    Genghao Chen, Thao Nguyen, Lindsay G. A. McKay, Sravya Sowdamini Nakka, Pan Hu, Julia McBride, Anthony C. T. Liang, Rachel M. Olson, James J. Moon, Andrew David Luster et al. · 2025 · Science Advances
67. Intranasal S-2P and lentinan formulation confers broad protection against SARS-CoV-2 VOCs via IFN-γ-dominant mechanisms
    Zhendong Pan, Xu Zheng, Liangliang Jiang, Cuiling Ding, Yangang Liu, Haoran Peng, Yan Liu, Yanhua He, Wanda Tang, Congcong Zhang et al. · 2026 · npj Vaccines
68. Ibuzatrelvir potently reduced viral RNA levels despite a high rate of anti-S seropositivity: a post hoc analysis of serology of the phase 2b study
    Jin Hyang Kim, Alex Knutson, Justin Smith, Shunjie Guan, Luke Chen, Mahta Mortezavi, Abigail Sloan, Anindita Banerjee, Mary Lynn Baniecki, Craig Hyde et al. · 2026 · Scientific Reports
69. Vaccine-derived T-cell responses are insufficient to generate protective immunity to SARS-CoV-2
    Soung-chul Cha, Szymon J. Szymura, Aaron Anderson, Zhenyuan Dong, Anmol Kandel, Elizabeth Oh, Michael Palmer, Kevin Arango, Jibin Zhang, Larry W. Kwak · 2026 · Scientific Reports
70. Caspase-11–mediated hyperinflammation impairs CD8+ T cell immunity and viral clearance in severe SARS-CoV-2 infection
    Mostafa M. Eltobgy, Mohamed M. Shamseldin, Owen D. Whitham, Heba M. Amer, Jeffrey Atkinson, Asmaa Badr, Jesse M. Hall, Gauruv A. Gupta, Yara Y. Hassan, Rabab ElMergawy et al. · 2026 · JCI Insight
71. Microbead-based extracorporeal immuno-affinity virus capture: a feasibility study to address the SARS-CoV-2 pandemic
    Gábor Járvás, Dora Szerenyi, H. Jankovics, F. Vonderviszt, J. Tóvári, L. Takacs, Fanni Foldes, B. Somogyi, F. Jakab, A. Guttman · 2023 · Microchimica Acta
72. mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
    Charlie Fricke, Lorenz Ulrich, Jana Kochmann, Janina Gergen, Kristina Kovacikova, Nicole Roth, Julius Beer, Daniel Schnepf, Thomas C. Mettenleiter, Susanne Rauch et al. · 2024 · Molecular Therapy — Nucleic Acids
73. Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations
    Zhendong Pan, Liangliang Jiang, Yingying Chen, Haoran Peng, Yangang Liu, Xu Zheng, Yanhua He, Yan Liu, Ying Wang, Xiaoyan Zhang et al. · 2025 · Journal of Virology
74. A SARS-CoV-2 peptide vaccine which elicits T-cell responses in mice but does not protect against infection or disease
    Victoria Kate Baxter, Elizabeth J. Anderson, Sharon Taft-Benz, Kelly Shea Olsen, Maria J. Sambade, Kaylee M. Gentry, Wolfgang A. Beck, Jason A. Garness, Allison Woods, Misha Fini et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
75. Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and Age
    Amelie E. Murrell, Ewono Eyoh, Jeffrey G. Shaffer, Monika L. Dietrich, Ivy V. Trinh, Thomas J. Yockachonis, Shuangyi Bai, Crystal Y. Zheng, Celia V. Mayne, Sofia E. Cabrera et al. · 2022 · medRxiv
76. An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecoviruses.
    Theocharis Tsoleridis, Chengcheng Fan, Emily J. Park, Joshua D. Duncan, Parul Sharma, Sophie Wartnaby, Joseph G. Chappell, Anja Kipar, Eleanor G. Bentley, Adam Kirby et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
77. Comparative analysis of antibody production by mRNA 1273, AZD 1222 and BBIBP-CorV on elderly people suffering from different co-morbidity in Bangladesh
    Ashraful M. Hoque, Md Marufur Rahman, Shahnewaz Parvez, Hossain Imam, Nurun Nahar, Forhad Uddin Hasan Chowdhury · 2021 · medRxiv
78. Comparison of the Clinical and Laboratory Findings and Outcomes of Hospitalized COVID-19 Patients who Were Vaccinated with Coronavac or Unvaccinated: An Analytical, Cross Sectional Study
    Serap Şimşek Yavuz, Gülşah Tunçer, Özlem Altuntaş Aydın, Mehtap Aydın, Filiz Pehlıvanoglu, Yeşim Tok, Sevim Meşe, Alper Gündüz, Ceyda Geyiktepe-Güçlü, İklima Özdoğan et al. · 2022 · Research Square
79. Assessment of the humoral immunity induced by Sputnik V Covid-19 vaccine (GAM-COVID-VAC) in healthcare workers
    Ezequiel Córdova, María Inés Lespada, Diego M. Cecchini, Fabiola Nieto, Susana Palonsky, Mariana Badran, Silvina Virginia Bernasconi, Brenda Bacelar, Laura Morganti, F. Garibaldi et al. · 2022 · Vacunas (English Edition)
80. A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice
    Bhawana Pandey, Zhengying Wang, Angela C. Jimenez, Eshant Bhatia, Ritika Jain, Alexander Beach, Drishti Maniar, Justin Hosten, Laura O’Farrell, Casey E. Vantucci et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
81. Cytolytic CD8+ T cell response to SARS-CoV-2 and non-SARS-CoV-2-related viruses is associated with severe manifestation of COVID-19
    Kristina Allers, Verena Moos, Jörg Hofmann, Mario Witkowski, Hildrun Haibel, Stefan Angermair, Thomas Schneider · 2023 · Clinical Immunology
82. Rewired type I IFN signaling is linked to age-dependent differences in COVID-19
    Lev Petrov, Sophia Brumhard, Sebastian Wisniewski, Philipp Georg, David Hillus, Anna Luisa Hiller, Rosario Astaburuaga-García, Nils Blüthgen, Emanuel Wyler, Katrin Vogt et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
83. SARS-CoV-2 spike protein is a self-adjuvanted antigen for mucosal immunization and confers broad protection against lethal challenge with SARS-CoV-2 via intranasal vaccination
    Ping Zhao, Zhendong Pan, Zheng Xu, Liangliang Jiang, Cui‐Ling Ding, Yangang Liu, Haoran Peng, Yan Liu, Yanhua He, Wanda Tang et al. · 2025 · Research Square
84. Targeting tuberculosis with LNP-mRNA vaccines: opportunities, challenges and future directions
    Hannah Lukeman, Elizabeth Chan, James A. Triccas · 2025 · Microbiology Australia
85. Retreatment or prolonged antiviral therapy in severe acute respiratory syndrome Coronavirus-2 infection among immunocompromised patients during 2022–2023: A nationwide claims-based cohort study in Japan
    Shinya Yamamoto, Kazuhiko Ikeuchi, Makoto Saito, Kazuya Okushin, Akira Kado, Satoshi Kitaura, Shu Okugawa, Takeya Tsutsumi · 2025 · Journal of Infection and Chemotherapy
86. Are older adults living with HIV more susceptible to omicron infection compared to their HIV-negative peers in China: a cross-sectional study
    Jianhui Yang, Esben S Strodl, Hongxia Xu, Haibo Jiang, Kun Chu, Shiwen Tan, Zehao Ye, Hongbo Shi, Weiqing Chen, Feng Tong · 2025 · Frontiers in Public Health
87. Additional file 7 of Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home
    María del Mar Pozo‐Balado, Ángel Bulnes‐Ramos, Israel Olivas‐Martínez, Vanesa Garrido‐Rodríguez, Carmen Lozano, Álvarez-Ríos, Ana I., Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara et al. · 2023 · DIGITAL.CSIC (Spanish National Research Council (CSIC))
88. Additional file 1 of Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home
    María del Mar Pozo‐Balado, Ángel Bulnes‐Ramos, Israel Olivas‐Martínez, Vanesa Garrido‐Rodríguez, Carmen Lozano, Álvarez-Ríos, Ana I., Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara et al. · 2023 · DIGITAL.CSIC (Spanish National Research Council (CSIC))
89. Additional file 4 of Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home
    María del Mar Pozo‐Balado, Ángel Bulnes‐Ramos, Israel Olivas‐Martínez, Vanesa Garrido‐Rodríguez, Carmen Lozano, Álvarez-Ríos, Ana I., Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara et al. · 2023 · DIGITAL.CSIC (Spanish National Research Council (CSIC))
90. Additional file 6 of Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home
    María del Mar Pozo‐Balado, Ángel Bulnes‐Ramos, Israel Olivas‐Martínez, Vanesa Garrido‐Rodríguez, Carmen Lozano, Álvarez-Ríos, Ana I., Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara et al. · 2023 · DIGITAL.CSIC (Spanish National Research Council (CSIC))
91. Additional file 3 of Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home
    María del Mar Pozo‐Balado, Ángel Bulnes‐Ramos, Israel Olivas‐Martínez, Vanesa Garrido‐Rodríguez, Carmen Lozano, Álvarez-Ríos, Ana I., Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara et al. · 2023 · DIGITAL.CSIC (Spanish National Research Council (CSIC))
92. Additional file 5 of Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home
    María del Mar Pozo‐Balado, Ángel Bulnes‐Ramos, Israel Olivas‐Martínez, Vanesa Garrido‐Rodríguez, Carmen Lozano, Álvarez-Ríos, Ana I., Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara et al. · 2023 · DIGITAL.CSIC (Spanish National Research Council (CSIC))
93. Additional file 8 of Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home
    María del Mar Pozo‐Balado, Ángel Bulnes‐Ramos, Israel Olivas‐Martínez, Vanesa Garrido‐Rodríguez, Carmen Lozano, Álvarez-Ríos, Ana I., Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara et al. · 2023 · DIGITAL.CSIC (Spanish National Research Council (CSIC))
94. Additional file 2 of Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home
    María del Mar Pozo‐Balado, Ángel Bulnes‐Ramos, Israel Olivas‐Martínez, Vanesa Garrido‐Rodríguez, Carmen Lozano, Álvarez-Ríos, Ana I., Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara et al. · 2023 · DIGITAL.CSIC (Spanish National Research Council (CSIC))
95. Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine
    Stina Gröhn, Heini Lehto, Saana Soppela, Rauno A. Naves, Mikael A. Ritvos, Alina Iakubovskaia, Vili Lampinen, Iiris Mustonen, Sanniina Pakkala, Elizaveta Husu et al. · 2026 · BMC Infectious Diseases
96. T immune responses to SARS-CoV-2 : identification of the immunogenic region associated with protection against infection
    Jean‐Eudes Fahrner · 2021 · theses.fr (ABES)
97. Functional neutralizing and bactericidal antibody responses induced by dual-target immunization with SARS-CoV-2 RBD and Neisseria meningitidis antigens in mice
    Amanda Izeli Portilho, Robert Andreata‐Santos, Márcia Duarte-Barbosa, Ana Paula Cunha Chaves, Hernan Hermes Monteiro da Costa, Nicoly Simões de Melo, Ana Flávia Segati, Giovanna Santos Oliveira, Carlos Roberto Prudêncio, Luiz Mário Janini et al. · 2026 · Vaccine